|
Market Closed -
NYSE
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.130 USD | +0.32% |
|
+0.64% | +13.82% |
| 19/08 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 14/08 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Chart calendar Perspective Therapeutics, Inc.
Upcoming events on Perspective Therapeutics, Inc.
No events available
Past events on Perspective Therapeutics, Inc.
| 11/08/2026 | Earnings release - Q2 2026 | |
| 27/05/2026 | Annual General Meeting | 07:30 pm |
| 12/05/2026 | Earnings release - Q1 2026 | |
| 04/05/2026 | Présentation aux Actionnaires / Analystes | 06:00 pm |
| 17/03/2026 | Earnings release - Annual 2025 | |
| 11/11/2025 | Earnings release - Q3 2025 | |
| 20/10/2025 | Information meeting | 06:00 pm |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,43 8,46 -83.04% | 1,45 1,46 -0.34% | 0,88 1,07 -17.46% | 0,34 | 0,40 | 0,92 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -64,5 -62,5 -3.18% | -110 -102 -8.35% | -125 | -139 | -145 |
|
EBIT Million USD | Released Forecast Spread | -40,9 -43,4 5.6% | -66,8 -67,1 0.48% | -114 -103 -9.76% | -124 | -142 | -150 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -40,1 -43,0 6.64% | -80,4 -58,1 -38.42% | -104 -95,1 -9.84% | -115 | -136 | -139 |
|
Net income Million USD | Released Forecast Spread | -46,5 -37,7 -23.33% | -79,3 -58,0 -36.62% | -103 -94,1 -9.57% | -116 | -135 | -143 |
|
EPS USD | Released Forecast Spread | -1,70 -1,40 -21.43% | -1,23 -0,66 -87.27% | -1,40 -1,25 -11.82% | -1,00 | -1,05 | -1,01 |
| Announcement Date | 28/03/24 | 26/03/25 | 16/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,23 0,28 -15.61% | 0,34 0,14 137.62% | 0,29 0,17 70.22% | 0,21 0,21 1.04% | 0,04 0,24 -81.86% | 0,08 0,14 -44.6% | 0,08 0,09 -12.39% | 0,05 | 0,05 | 0,05 | 0,01 | 0,01 | 0,01 |
|
EBITDA Million USD | Released Forecast Spread | -20,2 -17,6 -14.42% | -21,1 -19,5 -7.96% | -23,3 -19,8 -17.54% | -27,1 -21,7 -24.85% | -38,8 -25,5 -52.26% | -27,2 -39,7 31.6% | -28,1 -29,2 3.72% | -34,0 | -43,7 | ||||
|
EBIT Million USD | Released Forecast Spread | -20,9 -21,2 1.47% | -21,8 -23,0 5.05% | -24,0 -24,0 -0.28% | -27,9 -26,0 -7.32% | -39,8 -29,7 -33.98% | -28,3 -33,9 16.5% | -29,3 -30,5 4.08% | -31,5 | -33,7 | -32,4 | -33,5 | -34,6 | -35,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,3 -18,6 -122.37% | -18,2 -22,4 18.96% | -22,0 -22,5 2.33% | -26,0 -24,6 -5.7% | -38,3 -29,0 -31.92% | -26,2 -32,0 18.19% | -27,0 -29,1 7.27% | -29,7 | -31,4 | -30,9 | -32,1 | -33,6 | -34,9 |
|
Net income Million USD | Released Forecast Spread | -40,2 -18,5 -116.65% | -18,2 -22,4 18.96% | -21,5 -22,1 2.64% | -26,0 -24,4 -6.41% | -37,5 -28,3 -32.38% | -26,2 -32,2 18.77% | -26,8 -29,0 7.78% | -29,7 | -32,0 | -30,9 | -32,2 | -33,7 | -35,1 |
|
EPS USD | Released Forecast Spread | -0,61 -0,24 -152.55% | -0,25 -0,31 18.34% | -0,29 -0,30 2.08% | -0,35 -0,32 -7.88% | -0,51 -0,36 -40.94% | -0,25 -0,30 17.03% | -0,22 -0,26 14.27% | -0,25 | -0,26 | -0,26 | -0,27 | -0,27 | -0,28 |
| Announcement Date | 26/03/25 | 12/05/25 | 13/08/25 | 10/11/25 | 16/03/26 | 11/05/26 | 10/08/26 | - | - | - | - | - | - |
Past sector events for Perspective Therapeutics, Inc.
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CATX Stock
- Calendar Perspective Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
